Arrowhead Pharmaceuticals
Nasdaq ARWR · Pasadena, CA
Works in Genetic & rare · GI & liver · Immunology · Infectious disease · Metabolic & endocrine · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Respiratory · Women's health
Arrowhead Pharmaceuticals is a clinical trial sponsor based in Pasadena, CA, listed as Nasdaq ARWR. It has 12 active clinical trials with 2,009 planned participants, across 12 therapeutic areas. Since 2021 it has completed 23 trials and stopped 14 early.
Trial track record · since 2021
Financials · Nasdaq ARWR
Fundraising
Pipeline · 12 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is lead sponsor of 12 active clinical trials on ClinicalTrials.gov, with 2,009 planned participants, in Genetic & rare, GI & liver, Immunology, Infectious disease and other areas. Since 2021 it has completed 23 trials and stopped 14 early.
Arrowhead Pharmaceuticals is based in Pasadena, CA and is listed as Nasdaq ARWR. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Arrowhead Pharmaceuticals; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-13.
Approve Suite is not affiliated with Arrowhead Pharmaceuticals.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.